Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women

Clinical Infectious Diseases

Volumn 29, Issue 5, 1999, Pages 1145-1150

  Cu Uvin, Susan ^a,f   Hogan, Joseph W ^a   Warren, Dora ^b   Klein, Robert S ^c   Peipert, Jeffrey ^b   Schuman, Paula ^d   Holmberg, Scott ^b   Anderson, Jean ^e   Schoenbaum, Ellie ^c   Vlahov, David ^e   Mayer, Kenneth H ^a  

^a BROWN UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANDIDIASIS; CAUCASIAN; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; GENITAL TRACT INFECTION; GONORRHEA; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NEGRO; NEISSERIA GONORRHOEAE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SYPHILIS; TRICHOMONIASIS; VAGINITIS; WART VIRUS;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; GENITAL DISEASES, FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SYPHILIS; TRICHOMONAS INFECTIONS; VAGINOSIS, BACTERIAL;

EID: 0033503174     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313434     Document Type: Article

References (34)

1. 1. Centers for Disease Control and Prevention. HIV AIDS Surveill Rep 1997;9.
2. 2. Sun XW, Ellerbrock TV, Lungu O, Chiasson MA, Bush TJ, Wright TC Jr. Human papilloma virus infection in human immunodeficiency virus sero positive women. Obstet Gynecol 1995; 85:680-6.
3. 3. Chirgwin KD, Feldman J, Augenbraun M, Landesman S, Minkoff H. Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women. J Infect Dis 1995; 172:235-8.
4. 4. Chiasson MA, Ellerbrock TV, Bush TI, Sun XW, Wright TC Jr. Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with human immunodeficiency virus. Obstet Gynecol 1997; 89:690-4.
5. 5. Six C, Heard I, Bergeron C, et al. Comparative prevalence, incidence, and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS 1998; 12:1047-56.
6. 6. Rhoads JL, Wright C, Redfield RR, Burke DS. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987; 257:3105-7.
7. 7. Carpenter CCJ, Mayer KH, Stein M, Leibman BD, Fisher A, Fiore T. Human immunodeficiency virus infection in North American women: experience with 200 cases and a review of literature. Medicine 1991; 70:307-25.
8. 8. White M. Is vulvovaginal candidiasis an AIDS-related illness? Clin Infect Dis 1996; 22(Suppl 2):S124-7.
9. 9. Plummer FA, Simonsen JN, Chubb H, et al. Epidemiological evidence of the development of serovar-specific immunity after gonococeal infection. J Clin Invest 1989; S3:1472-6.
10. 10. Hutchinson CM, Rompalo AM, Reichart CA, Hook EW III. Characteristics of patients with syphilis attending Baltimore sexually transmitted disease clinics: multiple, high risk subgroups and interactions with HIV infections. Arch Intern Med 1991; 151:511-6.
11. 11. Spinillo A, Gorini G, Regazetti A, De Seta F, Nicola S, Zara C. Asymptomatic genitourinary chlamydia trachomatis infection in women sero-positive for human immunodeficiency virus infection. Obstet Gynecol 1994; 83:1005-9.
12. 12. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163:233-9.
13. 13. Greenblatt RM, Lukehart SA, Plummer FA, et al. Genital ulceration as a risk factor in human immunodeficiency virus infection. AIDS 1988; 2; 47-50.
14. 14. Wasserheit JN. Epidemiological synergy: interrelationships between HIV infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19: 61-77.
15. 15. Smith DK, Warren DL, Vlahov D, et al. Design and baseline participant characteristics of human immunodeficiency virus epidemiology research (HER) study; a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997; 146:459-69.
16. 16. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papilloma viruses. Cancer Cells 1989; 7:209-14.
17. 17. Amsel R, Totten PA, Spiegel CA, Chen KCS, Esehenbach DA, Holmes KK. Nonspecific vaginitis; diagnostic criteria and epidemiologic associations. Am J Med 1983; 74:14-22.
18. 18. Hosmer DW, Lemeshow S. Goodness of fit tests for the multiple logistic regression model. Communication Statistics 1980; 9:1043-69.
19. 19. Clark RA, Brandon W, Dumestre J, Pindaro C. Clinical manifestations of infection with human immunodeficiency virus in women in Louisiana. Clin Infect Dis 1993; 17:165-72.
20. 20. Fennema JSA, Van Aneijden FJC, Coutinho RA, Van den Hoek AJAR. Human immunodeficiency virus, sexually transmitted diseases, and gynecologic disorders in women: increased risk for genital herpes and warts among HIV-infected prostitutes in Amsterdam. AIDS 1995; 9:1071-8.
21. 21. Cohen CR, Duerr A, Pruithithada N, et al. Bacterial vaginosis and human immunodeficiency virus seroprevalence among female commercial sex workers in Chang Mai, Thailand. AIDS 1995; 9:1093-7.
22. 22. Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350:546-9.
23. 23. Lindsay MK, Adefris W, Willis S, Klein L. The risk of sexually transmitted diseases in HIV-infected parturients. Am J Obstet Gynecol 1993; 169: 1031-5.
24. 24. Burns DN, Tuomala R, Chang BH, et al. Vaginal colonization or infection with Candida albicans in human immunodeficiency virus infected women during pregnancy and during the postpartum period. Clin Infect Dis 1997; 24:201-10.
25. 25. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41:1-19.
26. 26. Webster LA, Berman SM, Greenspan JR. Surveillance for gonorrhea and primary and secondary syphilis among adolescents, United States 1981 1991. MMWR Morb Mortal Wkly Rep CDC Surveill Summ 1993; 42:1-11.
27. 27. Duerr A, Sierra MF, Feldman J, Clarke LM, Ehrlich I, Dehovitz J. Immune compromise and prevalence of candida vulvovaginitis in human immunodeficiency virus infceled women. Obstet Gynecol 1997; 90:252-56.
28. 28. Goldenberg RL, Klebanoff M, Nugent R, Krohn M, Hillier S, Andrews W. Bacterial colonization of the vagina during pregnancy in four ethnic groups. Am J Obstet Gynecol 1996; 174:1618-21.
29. 29. Centers for Disease Control and Prevention. Surveillance for primary and secondary syphilis United States, 1991. MMWR CDC Surveill Summ 1993; 42:13-9.
30. 30. Farhad BH, Ghassemi M, Roebuck KA, Spear GT. Activation of human immunodeficiency virus type 1 expression by Gardnerella vaginalis. J Infect Dis 1999; 179:924-30.
31. 31. Alexander NJ. Sexual transmission of human immunodeficiency virus: virus entry into male and female genital tract. Fertil Steril 1990; 54:1-18.
32. 32. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994; 170:1597-601.
33. 33. Cohen M, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis; implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349:1868-72.
34. 34. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseuses on HIV infection in rural Tanzania: randomised controlled study. Lancet 1995; 346:530-6.